Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Health
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the
UnitedHealth First-Quarter Earnings, Revenue Up as Company Added Members
Business Earnings Company sees moderate health spending, but higher costs for drugs such as Ozempic Source link
Bud Light Faces Boycott Calls, but Punishing Brands Is Harder Than It Looks
CMO Today Research shows recent social-media calls to boycott brands such as Goya and Spotify haven’t meaningfully hurt sales and at times briefly had the
National CineMedia Files for Bankruptcy as Latest Casualty of Cinema Slump
National CineMedia LLC, the largest movie-theater advertisement business in North America, filed for bankruptcy Tuesday after facing years of challenges from reduced attendance at cinemas
Former Outcome Health Executives Found Guilty of Fraud
Business Health Care Health Verdict caps fall of startup’s executive team led by Rishi Shah, who could face years in prison Source link
Investors Warm Back Up to Health Insurance Stocks After Selloff
Markets UnitedHealth, CVS shares have rallied in April ahead of earnings Source link
China Consumer Price Growth Eases, Reflecting Caution on the Economy
Economy Asia Economy While the scrapping of Covid controls has opened up the economy, joblessness and an uncertain outlook have kept a lid on domestic
Tonal Founder Steps Down as CEO
The at-home fitness company completed its latest funding round at a fraction of its prior valuation. Source link
Health Care Sector Update for 04/10/2023: PFE, VRTX, CANF, PHG
Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV)
Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis
Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs. Source link